References
Zelis R, Mason DT, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. J Clin Invest 1968;47:960-970.
Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.
Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63: 645-651.
Zelis R, Longhurst J, Capone RJ, Mason DT. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation 1974;50:137-143.
Bohm M, Morano I, Pieske B, et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 1991;68:689-701.
Ruegg JC. Effects of new inotropic agents on Ca2+ sensitivity of contractile proteins. Circulation 1986;73(Suppl. III): III78-III83.
Pouler H, Hanet C, Schroder E, et al. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure. J Cardiovasc Pharmacol 1989;14(Suppl.):S18-S22.
Walter M, Liebens I, Goethals H, Renard M, Dresse A, Bernard R. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses. Br J Clin Pharmacol 1988;25:323-329.
Katz SD, Kubo SH, Jessup M, et al. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure. Am Heart J 1992;123:95-103.
Satoh H, Ikenouichi H, Aoyagi T, et al. Acute hemodynamic effects of nilvadipine, a new calcium channel blocker, in patients with congestive heart failure. J Cardiovasc Pharm 1990;15:317-322.
Kubo SH, Gollub S, Bourge R, et al. for the Pimobendan Multicenter Research Group. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. Circulation 1992;85:942-949.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumoto, A., Momomura, Si., Yokoyama, I. et al. Pimobendan Has a Potent Venodilating Action in Patients with Congestive Heart Failure. Cardiovasc Drugs Ther 12, 595–597 (1998). https://doi.org/10.1023/A:1007755907820
Issue Date:
DOI: https://doi.org/10.1023/A:1007755907820